BillionToOne, Inc.
BLLN
Positions held
Your positionsBLLN isn't in your positions.
Add it to see shares, cost, and P&L here.
Bull / bear case
Site-generated summary from fundamentals, news, and score — not investment advice. As of 2026-10-08.
- BillionToOne, Inc. operates in the rapidly growing diagnostics and research sector, which is expected to expand significantly due to increasing demand for innovative healthcare solutions.
- The company has demonstrated a revenue growth of 64.4% year-over-year, indicating strong market traction.
- BillionToOne's gross margin stands at 71.3%, showcasing its ability to maintain profitability despite competitive pressures.
- The company's operating margin has compressed to 5% in the latest quarter, raising concerns about cost management and profitability.
- BillionToOne's trailing P/E ratio is 158.6, suggesting that the stock may be overvalued compared to its earnings potential.
- The stock's current score is neutral at 12.00, indicating mixed signals from technical indicators and market trends.
Fundamentals
| Market cap | $4.50B | Enterprise value | $4.10B | Trailing P/E | 151.44 | Forward P/E | 64.25 |
| PEG | — | Price / book | 8.32 | Beta | — | Dividend yield | 0.00% |
| Revenue growth | 64.4% | Earnings growth | — | Gross margin | 71.3% | Operating margin | 5.0% |
| Profit margin | 8.3% | ROE | 10.7% | ROA | 5.2% | Debt / equity | 0.27 |
| Current ratio | 11.69 | Free cash flow | $12.03M | Analyst recommendation | strong_buy | Mean target | $129.00 |
| 52w high | $150.44 | 52w low | $61.96 |
Quarterly
| 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | |
|---|---|---|---|---|---|
| Revenue | $109M | $108M | $96.1M | $83.5M | $66.6M |
| Op margin | 5.0% | 16.5% | 10.8% | 11.5% | -2.4% |
| Net income | $8.1M | $18.0M | $6.0M | $5.7M | -$0.2M |
| Gross margin | 70.5% | 73.0% | 71.4% | 69.9% | 65.3% |
| Gross profit | $77.1M | $79.1M | $68.6M | $58.4M | $43.5M |
| Operating income | $5.5M | $17.8M | $10.3M | $9.6M | -$1.6M |
- Revenue +1% vs prior quarter ($109M vs $108M).
- Gross margin 70.5% (was 73% prior quarter).
- Operating margin compressed to 5%.
Yearly (6y)
| 2025 | 2024 | 2023 | |
|---|---|---|---|
| Revenue | $305M | — | — |
| Op margin | 5.3% | — | — |
| Net income | $7.5M | — | — |
| Gross margin | 68.3% | — | — |
| Gross profit | $208M | — | — |
| Operating income | $16.0M | — | — |
No flags
• No distress or material-risk keywords in recent headlines (keyword scan only — not a guarantee).
News
2026-10-08 · BillionToOne Insider Sold Shares Worth $2,162,950, According to a Recent SEC Filing
2026-10-03 · BillionToOne (NasdaqGS:BLLN) Stock Fair Value Edges Higher As Analysts Weigh Tech And Reimbursement Risk
2026-10-01 · BillionToOne Insider Sold Shares Worth $1,326,919, According to a Recent SEC Filing
2026-09-28 · Billiontoone Insider Sold Shares Worth $416,625, According to a Recent SEC Filing
2026-09-23 · BillionToOne (BLLN) Stock Could Be A Bargain As It Jumps 30% YTD
2026-09-23 · BillionToOne Stock Jumped 12% Yesterday. Here’s What the Streets Target.
2026-09-21 · BillionToOne SVP Sells 1,416 Shares
2026-09-17 · BillionToOne CEO Liquidates Entire Directly-Held Stake in the Company for $3 Million
2026-09-17 · BillionToOne Insider Sold Shares Worth $3,030,444, According to a Recent SEC Filing
2026-09-14 · Billiontoone Insider Sold Shares Worth $1,975,400, According to a Recent SEC Filing
2026-09-02 · BillionToOne to Participate in the Wells Fargo 21st Annual Healthcare Conference
Price (daily)
Full chart · RSI · MACD · patterns